Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

ax pharmaceutical corp - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 12375 g in 12500 g

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy: enrofloxacin 100 injection is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-daytherapy: enrofloxacin 100 injection is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: enrofloxacin 100 injection is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. enrofloxacin 100 injection is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with escherichia coli has been diagnosed.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy:  enrofloxacin 100 mg/ml is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-day therapy:  enrofloxacin 100 mg/ml is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: enrofloxacin 100 mg/ml is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. enrofloxacin 100 mg/ml is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with escherichia coli has been diagnosed.

Sepanyol - Inggeris - HMA (Heads of Medicines Agencies)

global vet health sl - enrofloxacin 100 mg - oral solution - chicken, turkeys - enrofloxacin

Hungary - Inggeris - HMA (Heads of Medicines Agencies)

global vet health sl - enrofloxacin 100 mg - oral solution - chicken, turkeys - enrofloxacin

Portugal - Inggeris - HMA (Heads of Medicines Agencies)

global vet health sl - enrofloxacin 100 mg - oral solution - chicken, turkeys - enrofloxacin

Romania - Inggeris - HMA (Heads of Medicines Agencies)

global vet health sl - enrofloxacin 100 mg - oral solution - chicken, turkeys - enrofloxacin

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

norbrook laboratories limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 100 mg in 1 ml - cattle - single-dose therapy: enroflox 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis . cattle - multiple-day therapy: enroflox 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: enroflox 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis , bordetella bronchiseptica and mycoplasma hyopneumoniae . enroflox 100 is indicated for the control of colibacillosis in groups or pens of weaned pig

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

bayer limited - enrofloxacin - oral suspension - 25 mg/ml - enrofloxacin - feline - antibacterial

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

novartis animal health us, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg